Former United States Securities and Exchange Commission attorney Willie
Briscoe and the securities litigation firm of Powers
Taylor LLP are investigating potential claims against the Board of
Directors of Allergan, Inc. ("Allergan") (NYSE: AGN) concerning the
board's receipt of an unsolicited acquisition proposal from Valeant
Pharmaceuticals International Inc. Under the acquisition proposal,
valued at approximately $46 billion, Valeant intends to commence a
tender offer to acquire all of the outstanding shares of Allergan common
stock. The consideration, which includes $48.30 in cash and 0.83 shares
of Valeant, values Allergan at approximately $12.88 per share. Since
the announcement of the proposal, Allergan stock has jumped to $169.95
and according to an analyst's opinion, Allergan could be worth as much
as $200 per share.
If you are an affected investor, and you want to learn more about the
investigation or if you have information that you believe would be
helpful to the determination of the fairness of the proposed
transaction, contact Willie Briscoe at The Briscoe Law Firm, PLLC, (214)
239-4568, or via email at WBriscoe@TheBriscoeLawFirm.com,
or Patrick Powers at Powers Taylor LLP, toll free (877) 728-9607, via
e-mail at email@example.com.
There is no cost or fee to you.
The investigation centers on whether Allergan's Board of Directors is
acting in the shareholders' best interests, whether the board is
properly negotiating a higher share price for the shareholders, and
whether the board has employed an adequate process to review and act on
the proposed transaction. Notably, at least one analyst with Yahoo!
Finance believes that the true inherent value of the stock could be as
high as $200 per share.
Briscoe Law Firm, PLLC is a full service business litigation and
shareholder rights advocacy firm with more than 20 years of experience
in complex litigation and transactional matters.
Taylor LLP is a boutique litigation law firm that handles a variety
of complex business litigation matters, including claims of investor and
stockholder fraud, shareholder oppression, shareholder derivative suits,
and security class actions.
[ Back To NFVZone's Homepage ]